Showing 1 - 10 of 1,665
to 1990. We consider prescription opioids and have a close proxy for addiction to illicit opioids. We find that, if at … least one parent is using illicit opioids, the likelihood of the child using increases from 1.1 to 6.1%. For prescription … opioids, we observe an increase from 4.6 to 7.7%. Both associations are stable and do not change when controlling for …
Persistent link: https://www.econbiz.de/10012239591
to 1990. We consider prescription opioids and have a close proxy for addiction to illicit opioids. We find that, if at … least one parent is using illicit opioids, the likelihood of the child using increases from 1.1 to 6.1%. For prescription … opioids, we observe an increase from 4.6 to 7.7%. Both associations are stable and do not change when controlling for …
Persistent link: https://www.econbiz.de/10012232057
births from 1984 to 1990. We consider prescription opioids and a new proxy for addiction to illicit opioids. We find that, if … at least one parent is using illicit opioids, the likelihood of the child using increases from 1.1 to 7.1%. For … prescription opioids, we observe an increase from 4.6 to 7.7%. Both associations are stable and do not change when controlling for …
Persistent link: https://www.econbiz.de/10012234528
Persistent link: https://www.econbiz.de/10013461829
drug policy, actual policies appear not to have caught up with this rhetoric. There is a lingering over-emphasis in … narcotic drug policies on policing and incarceration at the expense of urgently needed investment in health and social services …, mostly in the European Union, highlights that bringing public health evidence into the center of drug policy decision …
Persistent link: https://www.econbiz.de/10012261465
Persistent link: https://www.econbiz.de/10012542297
Persistent link: https://www.econbiz.de/10012594197
Persistent link: https://www.econbiz.de/10011898882
Persistent link: https://www.econbiz.de/10014443699
Despite the fact that 30 percent of opioid overdoses also involve a benzodiazepine, there is little policy guidance on how to curb concurrent misuse and even less evidence on how changes to co-prescribing practices can affect patients' economic trajectories. In 2012, Austria restricted access to...
Persistent link: https://www.econbiz.de/10015044926